Jove
Visualize
Contact Us

Related Experiment Videos

Invasive pulmonary aspergillosis.

S R Doffman1, S G Agrawal, Jeremy S Brown

  • 1Barts & the London NHS Trust, West Smithfield, London, EC1A 7BE, UK. s.doffman@qmul.ac.uk

Expert Review of Anti-Infective Therapy
|August 19, 2005
PubMed
Summary

Invasive aspergillosis is a serious fungal infection with high mortality. New diagnostic tools and antifungal drugs like voriconazole offer improved treatment options and hope for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One Health genomic surveillance identified high-risk carbapenem-resistant ST821 clones of <i>Acinetobacter baumannii</i> in Nigerian clinical and community settings.

Microbial genomics·2026
Same author

Investigation of the essential role of capsular polysaccharide in serotype 1 <i>Streptococcus pneumoniae</i>.

Frontiers in cellular and infection microbiology·2026
Same author

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

The Journal of infectious diseases·2026
Same author

Biofilm formation during pneumococcal carriage imprints naturally acquired humoral immunity.

bioRxiv : the preprint server for biology·2025
Same author

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.

The Lancet. Respiratory medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Invasive aspergillosis presents a significant clinical challenge with high mortality rates (up to 80%) in susceptible individuals.
  • Early diagnosis of invasive aspergillosis is difficult, often leading to empirical antifungal treatment with associated costs and toxicities.
  • Limited effective antifungal agents were available until recently, complicating the management of this severe infection.

Purpose of the Study:

  • To highlight the challenges in diagnosing and treating invasive aspergillosis.
  • To discuss the impact of new antifungal agents and diagnostic techniques on patient outcomes.
  • To provide an outlook on the future management of invasive aspergillosis.

Main Methods:

  • Review of current clinical practices and therapeutic options for invasive aspergillosis.
  • Discussion of recent advancements in microbiologic diagnostic techniques.
  • Analysis of the role of novel antifungal drugs, including voriconazole and caspofungin.

Main Results:

  • Introduction of voriconazole and caspofungin has expanded treatment choices for invasive aspergillosis.
  • Advancements in microbiologic techniques are improving early diagnosis capabilities.
  • These combined advances offer potential for significant reductions in morbidity and mortality.

Conclusions:

  • Newer antifungal therapies and improved diagnostics represent a hopeful advancement in managing invasive aspergillosis.
  • The combination of effective drugs and earlier detection is expected to improve patient survival and reduce disease burden.
  • Continued research and implementation of these advancements are crucial for better patient outcomes in the coming years.

Related Experiment Videos